Form 4: GE HealthCare CEO Plans Share Sale for Tax Obligations

Sentiment:

Insider Transaction Report


GE HealthCare Technologies Inc. CEO, PDx Kevin Michael O'Neill reported a planned disposition of 462 shares of common stock for tax withholding related to RSU vesting.

Summary

  • Kevin Michael O'Neill, CEO, PDx of GE HealthCare Technologies Inc., reported a planned disposition of 462 shares of common stock.
  • The transaction is scheduled for February 1, 2026, at a price of $78.97 per share.
  • This disposition is intended to satisfy tax withholding obligations associated with the vesting of restricted stock units, as part of a pre-arranged Rule 10b5-1 plan.
  • Following this planned transaction, O'Neill will directly own 22,518 shares and indirectly own 59 shares through a share incentive plan trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the disposition of shares is a standard procedure for executives to cover tax liabilities associated with restricted stock unit vesting, not an indicator of sentiment towards the company's future.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those for tax withholding purposes and executed under a Rule 10b5-1 plan, are common across all industries and typically do not signal a change in company fundamentals or management's long-term outlook. This transaction is specific to an individual's compensation structure rather than a strategic move.

Stakeholder Impact

  • Minimal direct impact on shareholders as this is a routine, small-scale transaction for tax purposes, not a significant change in ownership or company strategy.

Key Dates

DateDescription
02/01/2026Transaction date for the planned disposition of common stock.
02/03/2026Date the Form 4 was signed.

Recommendation

hold

This Form 4 details a routine disposition of shares by an executive to cover tax obligations related to restricted stock unit vesting, executed under a Rule 10b5-1 plan. Such transactions are common and do not typically reflect a change in the company's fundamentals or the executive's long-term confidence. Therefore, it does not provide a basis for altering an existing investment thesis, warranting a 'hold' recommendation.

Keywords

GE HealthCare Technologies, GEHC, Insider Transaction, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Kevin Michael O'Neill, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.